{
  "buildId": "NSDuYoJl8cxdTqEyCvTi0",
  "gssp": true,
  "isFallback": false,
  "page": "/calc/[...slug]",
  "props": {
    "__N_SSP": true,
    "pageProps": {
      "calc": {
        "before_use": "",
        "calc_type": "calculator",
        "chief_complaint_en": [
          "Flank Pain",
          "Hematuria"
        ],
        "cmeEndDate": null,
        "cmeLastReviewed": null,
        "cmeReleaseDate": null,
        "cmeVersion": null,
        "cme_status": "",
        "content": {
          "about": {
            "evidence_based_medicine_en": "",
            "formula_en": "<ul>\n<li><strong>Grade 1</strong>\n<ul>\n<li>The nuclei of the tumor cells are small (&lt; 10 &micro;m), hyperchromatic, and round (resembling mature lymphocytes), with no visible nucleoli and little detail in the chromatin, as shown in the image below.</li>\n</ul>\n</li>\n<li><strong>Grade 2</strong>\n<ul>\n<li>Using the 10&times; objective, the nuclei of the tumor cells are slightly larger (15 &micro;m) with finely granular &ldquo;open&rdquo; chromatin but small, inconspicuous nucleoli (see the following image). The nucleoli are often present, and many appear as small chromocenters at 10&times; objective, with confirmation of their nature at higher power, but this does not count.</li>\n</ul>\n</li>\n<li><strong>Grade 3</strong>\n<ul>\n<li>Using the 10&times; objective, the nuclei of the tumor cells are larger (20 &micro;m in size) and may be oval in shape, with coarsely granular chromatin (see the image below). The nucleoli are easily unequivocally recognizable.</li>\n</ul>\n</li>\n<li><strong>Grade 4</strong>\n<ul>\n<li>The nuclei are pleomorphic with open chromatin or hyperchromatic and single or multiple macronucleoli, as depicted in the following image:</li>\n</ul>\n</li>\n</ul>\n<p><img style=\"max-width: 100%;\" src=\"https://cdn-web-img.mdcalc.com/fuhrman.jpeg\" alt=\"\"></p>",
            "more_info_en": "<p>More recent studies have shown 2- and 3-tier grading systems for the Fuhrman Scale are equally as effective.</p>",
            "references_list": {
              "Clinical Practice Guidelines": [],
              "Manufacturer Website": [],
              "Original/Primary Reference": [
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/7180965",
                  "text": "Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982 Oct;6(7):655-63."
                }
              ],
              "Other References": [
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/11250993",
                  "text": "Zisman A, Pantuck AJ, Dorey F, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol. 2001 Mar 15. 19(6):1649-57. "
                },
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/12454113",
                  "text": "Zisman A, Pantuck AJ, Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 2002 Dec 1. 20(23):4559-66."
                },
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/12173325",
                  "text": " Minervini A, et al. Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma. Long-term analysis in 213 patients. Cancer. 2002 May 15;94(10):2590-5."
                }
              ],
              "Outcomes": [],
              "Validation": [
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/15573369",
                  "text": "Ficarra V, Martignoni G, Maffei N, et al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer. 2005 Jan 1. 103(1):68-75."
                },
                {
                  "href": "https://onlinelibrary.wiley.com/doi/10.1002/cncr.22463/full",
                  "text": "Rioux-Leclercq N, Karakiewicz PI, Trinh QD, Ficarra, V, Cindolo L, et. al. Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer, 2007; 109: 868–874. doi: 10.1002/cncr.22463"
                },
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/20399450",
                  "text": "Klatte T, Anterasian C, Said JW, de Martino M, Kabbinavar FF, Belldegrun AS, Pantuck AJ. Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma. J Urol. 2010 Jun;183(6):2143-7. doi: 10.1016/j.juro.2010.02.023."
                }
              ],
              "Validations": []
            }
          },
          "contributor": {
            "expert_name": []
          },
          "creator": [
            {
              "approved": null,
              "name": "Dr. Susan A. Fuhrman",
              "qa_en": ""
            },
            {
              "approved": null,
              "name": "Dr. Nathalie Rioux-Leclercq",
              "qa_en": ""
            }
          ],
          "how_to_use": {
            "pearls_pitfalls_en": "<p>The Fuhrman Nuclear Grade is a pathology component of renal cell cancers and an independent predictor of cancer-specific survival. Virtually all data are from chart or database reviews and predate modern targeted therapies, but typically worsening nuclear grade correlates with worsening prognosis.</p>",
            "use_case_en": "<p>Patients with clear cell <abbr title=\"Renal Cell Carcinoma\">RCC</abbr> and pathology assessment available.</p>",
            "why_use_en": "<p>There are no validated scoring systems for predicting survival in clear cell RCC. Using the Fuhrman grade or scoring systems that integrate it may help delineate categories of survival time better than clinical judgment alone.</p>"
          },
          "next_steps": {
            "advice_en": "<p>The Fuhrman grade, like most other predictors for clear cell RCC prognosis, has not been prospectively tested and validated. However retrospective findings across studies are fairly consistent and Fuhrman grade is now a necessary component of some other scoring systems. The numerical survival estimates, it should be noted, are likely to be different in patients receiving targeted modern therapy.</p>",
            "critical_actions_en": "<p>The Fuhrman grade is not known to be accurate for individual survival prediction and should be considered a general guide rather than a reliable predictor. Consistency in pathological grading is critical.</p>",
            "management_en": "<p>We are unaware of validated management algorithms using the score.</p>"
          },
          "related_resources": {
            "interests": [
              {
                "description": "",
                "link": "https://www.mdcalc.com/rcc-renal-cell-carcinoma-practice-pearls",
                "text": "Practice Pearls: Renal Cell Carcinoma"
              }
            ]
          },
          "reviewer": []
        },
        "disabled": false,
        "disabled_reason": null,
        "disease_en": [
          "Chemotherapy",
          "Renal Cell Carcinoma"
        ],
        "dosing": false,
        "equation_logic": "f8b7fea3fc24cd892fca71f8583bd321",
        "equation_logic_text": "var calc_output = [];\n\nvar dia = parseInt(dia);\nvar shape =  parseInt(shape);\nvar nucleoli =  parseInt(nucleoli);\nvar biz = parseInt(biz);\n\nvar grade, surv, msg;\n\n\nif (dia == 1 && shape >= 1 && nucleoli >= 1) {grade = 'Grade I'; surv='96% Survival'; msg='<br/><br/>Per Original Study: Tumors classified as Nuclear Grade 1 did not metastasize for at least 5 years.';}\n\nif (dia == 1 && shape == 1 && nucleoli == 1) {grade = 'Grade I'; surv='96% Survival'; msg='<br/><br/>Per Original Study: Tumors classified as Nuclear Grade 1 did not metastasize for at least 5 years.';}\n\nif (dia == 2 && shape >= 1 && nucleoli >= 1) {grade = 'Grade II'; surv='84% Survival'; msg='';}\n\nif (dia == 2 && shape == 2 && nucleoli == 2) {grade = 'Grade II'; surv='84% Survival'; msg='';}\n\nif (dia == 3 && shape >= 1 && nucleoli >= 1 && biz == 1) {grade = 'Grade IV'; surv='31% Survival'; msg='';}\n\nif (dia == 3 && shape >= 1 && nucleoli >= 1 && biz == 0) {grade = 'Grade III'; surv='59% Survival'; msg='';}\n\nif (dia == 3 && shape == 3 && nucleoli ==3 && biz == 1) {grade = 'Grade IV'; surv='31% Survival'; msg='';}\n\n\ncalc_output.push({ name: 'mini', value: grade, value_text: '', message: surv });\ncalc_output.push({ name: 'Fuhrman Grade', value: grade, value_text: '', message: surv+msg });",
        "favorite_id": 3012,
        "full_title_en": "Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma",
        "input_schema": [
          {
            "conditionality": null,
            "default": null,
            "label_en": "Nuclear diameter",
            "mdcalc_info_concept": null,
            "name": "dia",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "Small (~10µm)",
                "value": 1
              },
              {
                "label": "Larger (~15µm)",
                "value": 2
              },
              {
                "label": "Even larger (~20µm)",
                "value": 3
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "radio"
          },
          {
            "conditionality": null,
            "default": null,
            "label_en": "Nuclear shape",
            "mdcalc_info_concept": null,
            "name": "shape",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "Round, uniform",
                "value": 1
              },
              {
                "label": "Irregularities in outline",
                "value": 2
              },
              {
                "label": "Obvious irregular outline",
                "value": 3
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "radio"
          },
          {
            "conditionality": null,
            "default": null,
            "label_en": "Nucleoli",
            "mdcalc_info_concept": null,
            "name": "nucleoli",
            "option_fhir_rules": null,
            "optional": false,
            "options": [
              {
                "label": "Absent, inconspicuous",
                "value": 1
              },
              {
                "label": "Visible at x400",
                "value": 2
              },
              {
                "label": "Prominent at x100",
                "value": 3
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "radio"
          },
          {
            "conditionality": null,
            "default": null,
            "label_en": "Bizarre often multilobed nuclei and/or spindle cells",
            "md_calc_info_concept": null,
            "name": "biz",
            "option_fhir_rules": null,
            "optional": true,
            "options": [
              {
                "label": "No",
                "value": 0
              },
              {
                "label": "Yes",
                "value": 1
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "toggle"
          }
        ],
        "instructions_en": "",
        "isVisibleInListView": true,
        "logic_language": "javascript",
        "logs": [],
        "md5": "5ecd25b779e088396d7d685be795a676",
        "medium_description_en": "<p>Provides prognostic grading system for tumor cells based on physical cellular appearance.</p>",
        "publishedAt": "2022-04-21T20:29:12.166Z",
        "purpose_en": [
          "Prognosis"
        ],
        "replacement_calc_id": null,
        "search_abbreviation_en": [
          "rcc",
          "renal",
          "kidney cancer",
          "kidney",
          "nucleus",
          "nucleoli",
          "chomatic"
        ],
        "search_id": "c-3012",
        "seo": {
          "keywords_en": "fuhrman, fuhrman score, rcc score, score, fuhrman score, rcc prognosis, fuhrman cancer score, fuhrman cancer prognosis, fuhrman rcc score, renal cell carcinoma score, fuhrman kidney cancer, kidney cancer score, metastatic rcc, localized rcc, tnm rcc, tnm fuhrman, tnm, fuhrman radiology, fuhrman grade, fuhrman diagnosis, fuhrman grading system, nuclear grading, nuclear grading system, fuhrman nuclear",
          "meta_description_en": "Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma provides prognostic grading system for tumor cells based on physical cellular appearance."
        },
        "short_description_en": "<p>Prognose RCC based on cellular appearance.</p>",
        "short_title_en": "Fuhrman Nuclear Grade",
        "slug": "fuhrman-nuclear-grade-clear-cell-renal-carcinoma",
        "specialty_en": [
          "Hematology and Oncology",
          "Hospitalist Medicine",
          "Internal Medicine",
          "Nephrology",
          "Radiation Oncology",
          "Radiology",
          "Urology"
        ],
        "system_en": [
          "Oncologic",
          "Renal"
        ],
        "tags": [],
        "versionNumber": 1,
        "versions": [],
        "vuid": "9ad84d42-9f6c-4e4c-969e-ef6f719b2ba5"
      },
      "contributors": [],
      "creators": [
        {
          "about_en": "<p>Susan A. Fuhrman, MD, is a practicing clinical and anatomic pathologist in Columbus, Ohio. She is Director of Pathology and Lab at OhioHealth Central Laboratories. Dr. Fuhrman is best known in the scientific medical community for developing the Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma.</p>",
          "createdAt": "2021-12-23T18:03:17.779Z",
          "deceased": null,
          "firstName": "",
          "lastName": "",
          "name": "Dr. Susan A. Fuhrman",
          "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-susan-a-fuhrman.jpeg",
          "publishedAt": "2021-11-17T15:11:30.452Z",
          "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Fuhrman%20SA%5BAuthor%5D",
          "signedCOI": false,
          "updatedAt": "2021-11-17T15:11:35.298Z"
        },
        {
          "about_en": "<p>Nathalie Rioux-Leclercq, MD is the head of the Pathological Anatomy and Cytology Service, part of the Department of Pathology and a professor of medicine at Rennes University Hospital in France. Her research focuses on renal cell carcinoma. prostatic adenocarcinoma, proliferation and apoptosis in the tumor process, and was lead author on the validation and reclassification of the Fuhrman Grade.</p>",
          "createdAt": "2021-12-23T18:03:17.779Z",
          "deceased": null,
          "firstName": "",
          "lastName": "",
          "name": "Dr. Nathalie Rioux-Leclercq",
          "photo_en": "https://cdn-web-img.mdcalc.com/people/default.jpeg",
          "publishedAt": "2021-11-17T15:11:30.452Z",
          "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Rioux-Leclercq+N%5BAuthor%5D",
          "signedCOI": false,
          "updatedAt": "2021-11-17T15:11:35.298Z"
        }
      ],
      "envs": {
        "CANONICAL_URL_ROOT": "https://www.mdcalc.com",
        "RECAPTCHA_PUBLIC_KEY": "6Lcu1mMkAAAAAAwmSDO3I7JNaUo9YtZ3jnrzTP6a",
        "STRAPI_TAG": "WEB_PROD",
        "STRIPE_PUB_KEY": "pk_live_yYm2UzDzaudhFgqWcKbv9vH7"
      },
      "faqs": [
        {
          "cme_faq": {
            "answer": "<p>MDCalc&rsquo;s Continuing Medical Education (CME) service allows users to easily earn AMA PRA Category 1 CreditsTM through regular use of MDCalc. Simply put, on top of getting the best medical calculators in the world, your usage will help you achieve your annual CME requirements, including specialty CME, without any extra effort.</p>",
            "createdAt": "2022-12-16T16:39:54.990Z",
            "publishedAt": "2022-12-16T16:39:55.697Z",
            "question": "What is MDCalc CME?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:52:48.348Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Yes, in support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MDCalc Ltd. Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p>",
            "createdAt": "2022-12-16T16:40:11.179Z",
            "publishedAt": "2022-12-16T16:40:11.883Z",
            "question": "Is MDCalc CME accredited?",
            "type": "Using",
            "updatedAt": "2023-02-09T18:38:00.345Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Only United States attending physicians, nurse practitioners, nurses, and physician assistants are eligible for our CME service.</p>",
            "createdAt": "2022-12-16T16:40:27.936Z",
            "publishedAt": "2022-12-16T16:40:28.851Z",
            "question": "Who can enroll and how?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:12.659Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>We have over 275 CME-eligible calculators across various specialties. You can read the clinical content supporting any CME calculators to start earning. Once you have viewed all the supporting content for a calculator, you will have officially earned the credit amount (0.5 credits) and will be able to redeem a certificate. For now, only calc content in CME-eligible calcs is eligible for CME credits, however, we&rsquo;ll be expanding our CME service to include more of our content in the future.</p>",
            "createdAt": "2022-12-16T16:40:47.203Z",
            "publishedAt": "2022-12-16T16:40:47.882Z",
            "question": "What activities can I do to earn CME credits?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:27.268Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Simply use our search bar or visit our homepage to easily find CME-eligible calcs. You must be enrolled in our CME service to see which calcs are CME-eligible.</p>",
            "createdAt": "2022-12-16T16:40:57.420Z",
            "publishedAt": "2022-12-16T16:41:02.863Z",
            "question": "Where can I find calcs with which I can earn credits?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:44.504Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Once you&rsquo;ve enrolled in our CME service, you will have a personal CME Dashboard where you can view all of your earned credits. You can navigate to the dashboard by clicking the CME button in the header at the top of any page.</p>",
            "createdAt": "2022-12-16T16:41:11.874Z",
            "publishedAt": "2022-12-16T16:41:13.038Z",
            "question": "Where can I see which credits I’ve earned?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:52.153Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Go to your CME Dashboard and select the credits you&rsquo;d like to redeem, fill out a few dropdown answers about how you used the calc, and then proceed to checkout.</p>",
            "createdAt": "2022-12-16T16:41:33.940Z",
            "publishedAt": "2022-12-16T16:41:35.646Z",
            "question": "How do I redeem CME credits?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:54:07.237Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>No. Earning credits as you use calcs is free, but either you (or your employer) will need to purchase an annual subscription to redeem your CME certificates.</p>",
            "createdAt": "2022-12-16T16:41:59.307Z",
            "publishedAt": "2022-12-16T16:42:00.078Z",
            "question": "Are CME credits free?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:54:22.467Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Just like with earned credits, you can view your CME certificates on your CME Dashboard in the &ldquo;CME Certificates&rdquo; tab. Certificates include a list of all of the calcs for which CME was earned along with a tally of the specialty CME.</p>",
            "createdAt": "2022-12-16T16:42:10.712Z",
            "publishedAt": "2022-12-16T16:42:15.215Z",
            "question": "Where can I see my CME certificates?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:54:32.826Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>One year from the date of purchase.</p>",
            "createdAt": "2022-12-16T16:42:52.839Z",
            "publishedAt": "2022-12-16T16:42:53.641Z",
            "question": "How long do credits in an annual subscription last?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:54:51.655Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>General; Addiction and Controlled Substances; Cardiac Care; Domestic and Intimate Partner Violence; Geriatrics; HIV and Infectious Disease; Hospice, End-of-Life, Terminal Illness, and Palliative Care; Mental and Behavioral Health; Pain Management; Pediatrics; Stroke; and Trauma.</p>",
            "createdAt": "2022-12-16T16:32:44.987Z",
            "publishedAt": "2022-12-16T16:32:46.006Z",
            "question": "What specialty CME credits are included in the plan?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:50:33.794Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Your gift card will be sent via email within 1-2 business days of making your purchase. You will be able to select from the following options - Visa, Amazon.com, Apple. Be sure to claim your gift card offer within 90 days of receiving the email.</p>\n<p>Your CME purchase may have implications for tax reporting purposes. The cost of your CME product may or may not be tax-deductible when used for professional purposes. Any reimbursed amount for incentives must be declared as personal income for tax purposes. Please consult your tax advisor. MDCalc does not provide tax advice.</p>",
            "createdAt": "2022-12-16T16:33:18.512Z",
            "publishedAt": "2022-12-16T16:33:19.250Z",
            "question": "I ordered a CME package with a gift card. How does it work?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:50:53.878Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Per the new guidelines from ACCME, the receipt will separate the cost you paid into the cost of the gift card and the cost of the CME learning activity.</p>",
            "createdAt": "2022-12-16T16:44:06.809Z",
            "publishedAt": "2022-12-16T16:44:07.518Z",
            "question": "What will show on my receipt for CME when it includes a gift card?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:55:08.549Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can get a refund (minus any promotional gift amount) within 30-days if the ease of earning and redeeming does not meet your expectations and if you have redeemed no more than 4 credits. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request a refund.</p>",
            "createdAt": "2022-12-16T16:36:44.877Z",
            "publishedAt": "2022-12-16T16:36:45.950Z",
            "question": "How do I get a refund if I'm not satisfied?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:51:01.761Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can upgrade your subscription throughout your billing cycle and pay the difference for a higher plan. You may request to downgrade your plan to a lower level to coincide with your next renewal. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request changes.</p>",
            "createdAt": "2022-12-16T16:37:26.433Z",
            "publishedAt": "2022-12-16T16:37:27.177Z",
            "question": "How do I later upgrade to a different plan if I need more credits?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:51:27.457Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Gift card plans are available for 1 year and do not auto-renew. Standard, non gift-card subscriptions are auto-renewed annually. You can disable the automatic renewal of your subscription at any time by emailing <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a>.</p>",
            "createdAt": "2022-12-16T16:44:53.580Z",
            "publishedAt": "2022-12-16T16:44:56.993Z",
            "question": "Do CME plans auto-renew?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:55:44.653Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>If you&rsquo;re part of a team or practice that wants to sign up five or more physicians, please email us at <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> for more information.</p>",
            "createdAt": "2022-12-16T16:38:26.466Z",
            "publishedAt": "2022-12-16T16:38:27.163Z",
            "question": "How do I get information on a discounted bulk subscription program for my institution, team, or practice?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:51:43.762Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>On July 28, 2022, ACCME updated the guidelines regarding the use of high-value incentives. These guidelines allow for the use of gift card rewards in a regulated manner. Visit the ACCME website to read their guidelines.</p>",
            "createdAt": "2022-12-16T16:46:21.538Z",
            "publishedAt": "2022-12-16T16:46:27.759Z",
            "question": "Did the ACCME decide to regulate gift cards?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:56:05.573Z"
          }
        }
      ],
      "headConfig": {
        "canonicalUrl": "/calc/3012/fuhrman-nuclear-grade-clear-cell-renal-carcinoma",
        "description": "Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma provides prognostic grading system for tumor cells based on physical cellular appearance.",
        "keywords": "fuhrman, fuhrman score, rcc score, score, fuhrman score, rcc prognosis, fuhrman cancer score, fuhrman cancer prognosis, fuhrman rcc score, renal cell carcinoma score, fuhrman kidney cancer, kidney cancer score, metastatic rcc, localized rcc, tnm rcc, tnm fuhrman, tnm, fuhrman radiology, fuhrman grade, fuhrman diagnosis, fuhrman grading system, nuclear grading, nuclear grading system, fuhrman nuclear",
        "title": "Fuhrman Nuclear Grade for Clear Cell Renal Carcinoma"
      },
      "isCMECalc": false,
      "measurements": [],
      "relCalcs": [
        {
          "calcId": 2153,
          "short_title_en": "MSKCC/Motzer Criteria for RCC",
          "slug": "memorial-sloan-kettering-cancer-center-mskcc-motzer-score-metastatic-renal-cell-carcinoma-rcc"
        },
        {
          "calcId": 3908,
          "short_title_en": "RENAL Nephrometry Score",
          "slug": "renal-nephrometry-score"
        },
        {
          "calcId": 2154,
          "short_title_en": "SSIGN Score",
          "slug": "ssign-score-renal-cell-carcinoma-rcc"
        }
      ],
      "societies": {
        "American Association for the Study of Liver Diseases": {
          "abbreviation": "AASLD",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.aasld.org/"
        },
        "American College Of Emergency Physicians": {
          "abbreviation": "ACEP",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/american-college-of-emergency-physicians-squarelogo.png",
          "web_link": "https://www.acep.org/"
        },
        "American College of Gastroenterology": {
          "abbreviation": "ACG",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/acg_logo.png",
          "web_link": "https://gi.org/"
        },
        "American College of Rheumatology": {
          "abbreviation": "ACR",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.rheumatology.org/"
        },
        "American Gastroenterological Association": {
          "abbreviation": "AGA",
          "description": "plain-text",
          "img": "https://apps.mdcalc.com/images/societies/aga.jpeg",
          "web_link": "https://gastro.org"
        },
        "American Heart Association": {
          "abbreviation": "AHA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/societies/+AHA+(American+Heart+Association).png",
          "target": "aha",
          "web_link": "http://www.heart.org/HEARTORG/"
        },
        "American Urological Association": {
          "abbreviation": "AUA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.auanet.org/"
        },
        "EB Medicine": {
          "abbreviation": "EB Medicine",
          "description": "EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.",
          "img": "https://cdn-web-img.mdcalc.com/other/eb_medicine-icon-only.jpg",
          "target": "eb-medicine",
          "web_link": "http://www.ebmedicine.net/"
        },
        "MDCalc CME": {
          "abbreviation": "MDCalc CME",
          "img": "https://cdn-web-img.mdcalc.com/Stroke-CME-content.jpg",
          "web_link": "https://www.mdcalc.com/stroke-cme?utm_source=NIHSS_calc&utm_medium=NIHSS_calc&utm_campaign=NIHSS_calc"
        },
        "OTHER": {
          "abbreviation": "OTHER"
        },
        "Postgraduate Institute for Medicine": {
          "abbreviation": "PIM",
          "description": "plain-text",
          "img": "https://cdn-web-img.mdcalc.com/PIM-circle-COLOR.jpeg",
          "target": "pim",
          "web_link": "https://www.pimed.com/"
        },
        "VACO Podcast": {
          "description": "Listen to the VACO co-creators break down how to use VACO\\, what it does\\, and what it doesn’t.",
          "img": "https://cdn-web-img.mdcalc.com/content/podcast 2.png",
          "web_link": "https://www.stimuluspodcast.com/post/32-the-covid-mortality-score-vaco"
        }
      },
      "validSections": [
        "whenToUseViewed",
        "pearlsPitfallsViewed",
        "whyUseViewed",
        "nextStepsViewed",
        "evidenceViewed"
      ]
    }
  },
  "query": {
    "slug": [
      "3012",
      "fuhrman-nuclear-grade-clear-cell-renal-carcinoma"
    ]
  },
  "scriptLoader": []
}